640290-67-1Relevant articles and documents
Concurrent Administration of Neu2000 and Lithium Produces Marked Improvement of Motor Neuron Survival, Motor Function, and Mortality in a Mouse Model of Amyotrophic Lateral Sclerosis
Shin, Jin Hee,Cho, Sung Ig,Lim, Hyang Ran,Lee, Jae Keun,Lee, Young Ae,Noh, Jai Sung,Joo, In Soo,Kim, Kee-Won,Gwag, Byoung Joo
, p. 965 - 975 (2007)
The Fas pathway and oxidative stress mediate neuronal death in stroke and may contribute to neurodegenerative disease. We tested the hypothesis that these two factors synergistically produce spinal motor neuron degeneration in amyotrophic lateral sclerosi
2-hydroxyl-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl benzylamino) benzoic acid and preparation method thereof
-
Page/Page column 8-10, (2018/07/06)
The invention provides high-purity 2-hydroxyl-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl benzylamino) benzoic acid and a preparation method of the high-purity 2-hydroxyl-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl benzylamino) benzoic acid. The content of the
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES
-
, (2012/03/08)
The present invention relates to a pharmaceutical composition and the method of use for treating or preventing burn injury in patients or subjects in need, including the compound represented by the specific chemical formula as an active ingredient or its pharmaceutically acceptable salts or solvates.
PROCESS OF PREPARATION OF SUBSTITUTED TETRAFLUOROBENZYLANILINE COMPOUND AND ITS PHARMACEUTICALLY APPROVED SALTS
-
, (2008/06/13)
This invention relates to a method for preparing tetrafluorobenzyl-5-aminosalicylic acid derivative and its pharmaceutically acceptable salt compounds. In particular, this invention relates to a method for preparing tetrafluorobenzyl-5-aminosalicylic acid